Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362369
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2024-03-21
Brief Title:
A Study of Oral 7HP349 Alintegimod in Combination with Ipilimumab Followed by Nivolumab Monotherapy
Sponsor:
7 Hills Pharma LLC
Organization:
7 Hills Pharma LLC
Organization Data
Organization:
7 Hills Pharma LLC
Class:
INDUSTRY
Study ID:
7HP-111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
7 Hills Pharma LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None